Susan E Graf is Director of Finch Therapeutics Group, Inc.. Currently has a direct ownership of 5,010 shares of FNCH, which is worth approximately $54,108. The most recent transaction as insider was on Jun 09, 2023, when has been sold 5,010 shares (Common Stock) at a price of $0.27 per share, resulting in proceeds of $1,352. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.01K
0% 3M change
0% 12M change
Total Value Held $54,108

Susan E Graf Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 09 2023
BUY
Open market or private purchase
$1,352 $0.27 p/Share
5,010 Added 50.0%
5,010 Common Stock

Also insider at

CGON
CG Oncology, Inc.
SEG

Susan E Graf

Director
Somerville, MA

Track Institutional and Insider Activities on FNCH

Follow Finch Therapeutics Group, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FNCH shares.

Notify only if

Insider Trading

Get notified when an Finch Therapeutics Group, Inc. insider buys or sells FNCH shares.

Notify only if

News

Receive news related to Finch Therapeutics Group, Inc.

Track Activities on FNCH